Zobrazeno 1 - 10
of 748
pro vyhledávání: '"Klobuch, S."'
Autor:
Borgers, J.S.W., van Schijndel, A.W., van Thienen, J.V., Klobuch, S., Seijkens, T.T.P., Tobin, R.P., van Heerebeek, L., Driessen-Waaijer, A., Rohaan, M.W., Haanen, J.B.A.G.
Publikováno v:
In ESMO Open February 2024 9(2)
Autor:
Pal SK; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California., Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Haanen JBAG; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Leiden University Medical Center, Leiden, the Netherlands.; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Hurwitz ME; Yale School of Medicine, New Haven, Connecticut., Sacher A; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Departments of Medicine and Immunology, University of Toronto, Toronto, Canada., Tannir NM; University of Texas MD Anderson Cancer Center, Houston, Texas., Budde LE; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California., Harrison SJ; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Klobuch S; Netherlands Cancer Institute, Amsterdam, the Netherlands., Patel SS; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Meza L; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California., Dequeant ML; CRISPR Therapeutics, Boston, Massachusetts., Ma A; CRISPR Therapeutics, Boston, Massachusetts., He QA; CRISPR Therapeutics, Boston, Massachusetts., Williams LM; CRISPR Therapeutics, Boston, Massachusetts., Keegan A; CRISPR Therapeutics, Boston, Massachusetts., Gurary EB; Formerly employed by CRISPR Therapeutics, Boston, Massachusetts., Dar H; CRISPR Therapeutics, Boston, Massachusetts., Karnik S; CRISPR Therapeutics, Boston, Massachusetts., Guo C; Formerly employed by CRISPR Therapeutics, Boston, Massachusetts., Heath H; CRISPR Therapeutics, Boston, Massachusetts., Yuen RR; CRISPR Therapeutics, Boston, Massachusetts., Morrow PK; Formerly employed by CRISPR Therapeutics, Boston, Massachusetts., Agarwal N; Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Srour SA; University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Jul 01; Vol. 14 (7), pp. 1176-1189.
Autor:
Los C; From the Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute., Klobuch S; Department of Medical Oncology, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam., Haanen JBAG
Publikováno v:
Cancer journal (Sudbury, Mass.) [Cancer J] 2024 Mar-Apr 01; Vol. 30 (2), pp. 113-119.
Autor:
Klobuch S; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Seijkens TTP; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Medical Biochemistry, Amsterdam University Medical Centers, Amsterdam, Netherlands., Schumacher TN; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Haanen JBAG; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. j.haanen@nki.nl.; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands. j.haanen@nki.nl.; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands. j.haanen@nki.nl.; Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. j.haanen@nki.nl.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2024 Mar; Vol. 21 (3), pp. 173-184. Date of Electronic Publication: 2024 Jan 08.
Autor:
Mackensen A; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Haanen JBAG; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands.; Leiden University Medical Center, Department of Oncology, Leiden, the Netherlands., Koenecke C; Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany., Alsdorf W; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Wagner-Drouet E; University Medical Center Mainz, 3rd Medical Department, Hematology and Oncology, Mainz, Germany., Borchmann P; University Hospital of Cologne, Department I of Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Heudobler D; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.; University Hospital Regensburg, Department of Internal Medicine III, Hematology and Oncology, Regensburg, Germany., Ferstl B; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Klobuch S; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands., Bokemeyer C; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Desuki A; University Medical Center Mainz, 3rd Medical Department, Hematology and Oncology, Mainz, Germany., Lüke F; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.; University Hospital Regensburg, Department of Internal Medicine III, Hematology and Oncology, Regensburg, Germany., Kutsch N; University Hospital of Cologne, Department I of Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Müller F; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Smit E; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands., Hillemanns P; Hannover Medical School, Department of Gynecology and Obstetrics, Hannover, Germany., Karagiannis P; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Wiegert E; Bexon Clinical Consulting, Upper Montclair, NJ, USA., He Y; BioNTech SE, Mainz, Germany., Ho T; BioNTech US, Cambridge, MA, USA., Kang-Fortner Q; BioNTech US, Cambridge, MA, USA., Schlitter AM; BioNTech SE, Mainz, Germany., Schulz-Eying C; BioNTech SE, Mainz, Germany., Finlayson A; BioNTech SE, Mainz, Germany., Flemmig C; BioNTech SE, Mainz, Germany., Kühlcke K; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany., Preußner L; BioNTech SE, Mainz, Germany., Rengstl B; BioNTech SE, Mainz, Germany.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Türeci Ö; BioNTech SE, Mainz, Germany.; BioNTech US, Cambridge, MA, USA.; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Şahin U; BioNTech SE, Mainz, Germany. Ugur.Sahin@biontech.de.; BioNTech US, Cambridge, MA, USA. Ugur.Sahin@biontech.de.; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany. Ugur.Sahin@biontech.de.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany. Ugur.Sahin@biontech.de.
Publikováno v:
Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2844-2853. Date of Electronic Publication: 2023 Oct 23.
Autor:
Betof Warner, A., Smithy, J.W., Los, C., Kalvin, H., Hasson, N., Amaria, R.N., Andrade Czapla, J.A., Schollenberger, M., furness, A., Hassel, J.C., Wermke, M., Ocejo Gallegos, J.A., Lutzky, J., Lipson, E.J., Sullivan, R.J., Kluger, H., Panageas, K., Klobuch, S., Haanen, J.B.A.G., Shoushtari, A.N.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S730-S731
Autor:
Haanen, J.B.A.G., Mackensen, A., Schultze-Florey, C., Alsdorf, W., Wagner-Drouet, E., Heudobler, D., Borchmann, P., Busse, A., Mielke, S., Bins, S., Ungerechts, G., Bokemeyer, C., Klobuch, S., Kutsch, N., Müller, F., Desuki, A., Zhong, W., Preussner, L., Türeci, Ö., Sahin, U.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S489-S490
Autor:
Klobuch S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Seijkens TTP; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Biochemistry, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Chinese clinical oncology [Chin Clin Oncol] 2023 Apr; Vol. 12 (2), pp. 19.
Autor:
Mackensen, A., Haanen, J.B.A.G., Alsdorf, W., Koenecke, C., Wagner-Drouet, E., Borchmann, P., Heudobler, D., Busse, A., Klobuch, S., Kutsch, N., Müller, F., Bokemeyer, C., Desuki, A., Lueke, F., Ho, T., Vemuri, K., Preussner, L., Rengstl, B., Türeci, Ö., Sahin, U.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S1274-S1275
Autor:
Borgers, J.S.W., Lenkala, D., McCarthy, B., Kohler, V., Hymson, S., Esaulova, K., Finney, O., Balogh, K., Klobuch, S., Nijenhuis, C., Gaynor, R.B., DeMario, M., Haanen, J.B.A.G., van Buuren, M.M.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S619-S619